- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04039490
Novel Device for Ultrasound-guided Pediatric Vessel Cannulations
July 29, 2019 updated by: Clear Guide Medical
Clinical Trial to investigate whether the use of a novel device to be used in conjunction with ultrasound in pediatric vessel cannulations is superior to ultrasound-only pediatric vessel cannulations in terms of number of cannulation attempts.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
Use of needle guidance plus ultrasound imaging for CVC placement in the pediatric high-risk population may facilitate the procedure with a single needle pass and decrease the incidence of adverse effects by minimizing additional needle passes.
This study will compare the use of ultrasound-only guidance with the Clear Guide SCENERGY guidance in terms of successful first-attempt vessel cannulations such as internal jugular and fermoral artery access.
The question is whether it is possible to make ultrasound-guided pediatric vascular access less technically challenging in order to improve adoption and utilization leading to decreased iatrogenic complications and improved patient safety.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dorothee Heisenberg, PhD
- Phone Number: 4435703835
- Email: heisenberg@clearguidemedical.com
Study Contact Backup
- Name: Kevin Cleary, PhD
- Phone Number: 202-476-3809
- Email: KCleary@childrensnational.org
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 month to 17 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- any pediatric patient scheduled for a vessel cannulation at CNMC
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Ultrasound-only Pediatric Vessel Cannulation
The standard of care for vessel cannulation currently employed at CNMC
|
|
EXPERIMENTAL: SCENERGY-guided Pediatric Vessel Cannulation
The addition of the SCENERGY guidance combined with the ultrasound for pediatric vessel cannulations.
|
Use of the SCENERGY guidance device in conjunction with ultrasound to guide needles for pediatric vessel cannulations
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Successful first-attempt vessel cannulation
Time Frame: 1 hour
|
Test if the vessel cannulation was successful with only 1 attempt --needle puncture--to reach the vessel
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Non-IR Personnel Successfully Cannulate Pediatric Patients
Time Frame: 1 hour
|
Test if non-specialists can learn to successfully cannulate pediatric patients with only 1 needle puncture.
|
1 hour
|
Point-of-Care Successful Cannulation
Time Frame: 1 hour
|
Test whether the SCENERGY makes possible successful pediatric vessel cannulations at patient's point of care location.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
September 1, 2020
Primary Completion (ANTICIPATED)
August 1, 2021
Study Completion (ANTICIPATED)
December 1, 2021
Study Registration Dates
First Submitted
July 29, 2019
First Submitted That Met QC Criteria
July 29, 2019
First Posted (ACTUAL)
July 31, 2019
Study Record Updates
Last Update Posted (ACTUAL)
July 31, 2019
Last Update Submitted That Met QC Criteria
July 29, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- CNMC Ph II Trial
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on SCENERGY
-
Clear Guide MedicalJohns Hopkins UniversityUnknownCT Guided Biopsy | CT Guided Drain Placement Within the Abdomen or Pelvis | CT Guided Injection of Muscle or Nerve Within the PelvisUnited States
-
Clear Guide MedicalNational Institutes of Health (NIH); Temple UniversityWithdrawnLiver Biopsy | Lung Biopsy | Kidney BiopsyUnited States
-
Clear Guide MedicalJohns Hopkins UniversityWithdrawn
-
Clear Guide MedicalUniversity of MarylandWithdrawn